Stock Events

Stock Events

SciSparc 

$3.66
54
+$0+0% Today

Statistics

Day High
3.95
Day Low
3.6
52W High
94.5
52W Low
3.5
Volume
3,398
Avg. Volume
175,132
Mkt Cap
1.96M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30JunExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-17.91
-11.94
-5.97
0
Expected EPS
0
Actual EPS
-0.7

Financials

-572.13%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
2.61MRevenue
-14.94MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SPRC. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap148.9M
Corbus Pharmaceuticals works on cannabinoid drug development, targeting similar therapeutic areas as SciSparc, making them direct competitors.
Aurora Cannabis
ACB
Mkt Cap280.01M
Aurora Cannabis is a major player in the cannabis industry, whose medical cannabis products could compete with SciSparc's cannabinoid-based therapeutics.
Canopy Growth
CGC
Mkt Cap418.51M
Canopy Growth Corporation operates in the cannabis and cannabinoid-derived product market, posing competition to SciSparc's product offerings.
Tilray Brands
TLRY
Mkt Cap1.5B
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, potentially competing with SciSparc in multiple markets.
Curaleaf
CURLF
Mkt Cap2.16B
Curaleaf Holdings is a leading U.S. provider of consumer products in cannabis, with a broad product portfolio that could compete with SciSparc's therapeutic offerings.

About

SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in soft gel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
Show more...
CEO
Mr. Oz Adler CPA
Employees
2
Country
IL
ISIN
IL0010951403

Listings

XNAS
US
SPRC
BOATS
BOATS
SPRC.BOATS

0 Comments

Share your thoughts

FAQ

What is SciSparc stock price today?▼
The current price of SPRC is $3.66 USD — it has increased by +0% in the past 24 hours. Watch SciSparc stock price performance more closely on the chart.
What is SciSparc stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange SciSparc stocks are traded under the ticker SPRC.
Is SciSparc stock price growing?▼
SPRC stock has fallen by -13.88% compared to the previous week, the month change is a -26.73% fall, over the last year SciSparc has showed a -93.11% decrease.
What is SciSparc market cap?▼
Today SciSparc has the market capitalization of 1.96M
What were SciSparc earnings last quarter?▼
SPRC earnings for the last quarter are -0.7 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SciSparc revenue for the last year?▼
SciSparc revenue for the last year amounts to 2.61M USD.
What is SciSparc net income for the last year?▼
SPRC net income for the last year is -14.94M USD.
How many employees does SciSparc have?▼
As of April 01, 2026, the company has 2 employees.
In which sector is SciSparc located?▼
SciSparc operates in the Health Care sector.
When did SciSparc complete a stock split?▼
The last stock split for SciSparc was on March 04, 2026 with a ratio of 1:9.
Where is SciSparc headquartered?▼
SciSparc is headquartered in Tel Aviv, IL.